Patents Assigned to DICE ALPHA, INC.
  • IL-17 ligands and uses thereof
    Patent number: 12234225
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: February 25, 2025
    Assignee: DICE ALPHA, INC.
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter Van Der Linden, Timothy J. Church, Claudio Aquino, Margot Paulick
  • IL-17 ligands and uses thereof
    Patent number: 11447468
    Abstract: Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: September 20, 2022
    Assignee: DICE ALPHA, INC.
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter Van der Linden, Timothy J. Church, Claudio Aquino, Margot Paulick
  • Substituted benzenecarboxamides as IL-17A modulators
    Patent number: 11274094
    Abstract: The disclosure herein provides compounds and pharmaceutical compositions for the modulation of IL-17A useful for the treatment of inflammatory conditions, such as psoriasis.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: March 15, 2022
    Assignee: DICE ALPHA, INC.
    Inventors: Paul R. Fatheree, Martin S. Linsell, John R. Jacobsen, Wouter A. Van Der Linden, Timothy J. Church, Claudio Aquino, Margot G. Paulick